Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Genitourinary 1Endocrine 1CNS 1

Conditions

Thyroid cancer, Hurthle cell 1Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Squamous Cell Carcinoma of Head and Neck 1Pheochromocytoma 1Parathyroid Neoplasms 1Paraganglioma 1Multiple Endocrine Neoplasia 1Kidney Neoplasms 1Hypoglycemia 1Hyperparathyroidism 1Hypercalcemia 1Head and Neck Neoplasms 1Adenocarcinoma, Follicular 1

Interventions

pembrolizumab 10atezolizumab 4Drug Therapy 4Nivolumab 3Filgrastim 3Cetuximab 3Carboplatin 3cemiplimab 2belinostat 2Peripheral Blood Stem Cell Transplantation 2Patient Reported Outcome Measures 2Fluorouracil 2Counseling 2Bupropion 2Bortezomib 2utomilumab 1tumor necrosis factor-alpha, CNGRC fusion protein, human 1tremelimumab 1tocilizumab 1tanespimycin 1seribantumab 1poly ICLC 1pentetreotide 1pazopanib 1oblimersen 1motexafin gadolinium 1mogamulizumab 1liposomal doxorubicin 1ixabepilone 1gallium Ga 68 dotatate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Kidney Neoplasms × gallium Ga 68 dotatate × Head & Neck × Clear all
NCT06479811 2026-04-28

[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers

National Institutes of Health Clinical Center (CC)

Phase 1 Recruiting
120 enrolled
CNSEndocrineGenitourinaryHead & Neck

Head and Neck Neoplasms, Kidney Neoplasms, Paraganglioma, Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡